Physicians wrestled with endpoint composition, low event rates, a possible difference in ischemic strokes, and more.

Boston Scientific (NYSE:BSX) announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.

Study suggests a path forward for device therapy, though caveats are plenty ...

Boston Scientific Corporation (NYSE: BSX) today announced that the CHAMPION-AF global clinical trial met all primary and secondary safety and efficacy endpoints. The study evaluated the WATCHMAN FLX™ ...

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

AFib, an irregular and often very fast heart rhythm, can lead to blood clots in the heart and significantly increase the ...

In patients with atrial fibrillation, those assigned left atrial appendage closure had similar ischemic outcomes and better bleeding outcomes compared with those assigned oral anticoagulation, ...

For patients with non-valvular atrial fibrillation (AFib) who had no contraindications to taking oral anticoagulants, the use of a device to close off the left atrial appendage in the heart—a small ...

The suit was filed by Spykar Lifestyles seeking recovery of ₹87 lakh with interest based on a lease deed executed between the ...

INDORE: Eighteen-year-old Mohnish, who ploughed his car through a group of residents leading to death of a woman at Shiv ...

As a staff writer for Forbes Advisor, SMB, Kristy helps small business owners find the tools they need to keep their businesses running. She uses the experience of managing her own writing and editing ...

A former chief deputy with the Hocking County Sheriff’s Office has been convicted of corruption charges following a jury ...